Cannim is pioneering a world class care ecosystem driven by tech-enabled scientific research, to provide a curated cannabinoid medicine offerings, delivered to patients across the globe. From seed to patient, we deliver a continuum of care, improving patient outcomes and experience through evidence-based therapies
 
Our global community of experts, innovators, academics, health care providers, patients and partner organisations collaborate to co-design impactful solutions. Through research, evidence-based education, and curating an increasing range of world-class plant based and holistic therapies, we deliver inclusive, accessible and affordable care.
 
Cannim’s expanding portfolio of plant-medicines is hand selected from a range of premium cultivators across the world, we serve the medical markets in Australia, the UK, EU, and North America. Supported by expert teams in Canada, Australia, UK & USA, we ensure healthcare practitioners can access consistent, expertly curated formulations tailored to patient needs, setting a new standard in patient-centered care.

Cannim

Andrew Yap

This department focuses on gathering, processing, and analyzing data to support decision-making and improve business outcomes.

Cannim

Org chart

Teams

Data Analysis

Offices